Madrid, Spain

Ivan Collado Cano

This inventor holds 1 USPTO granted patent. Top assignee: Lilly, Sa. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivan Collado Cano. Retrieved from https://idiyas.com/inventor/ivan-collado-cano-tzl2a9gl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ivan Collado Cano

Introduction

Ivan Collado Cano is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts. His work has led to the creation of a pharmaceutical compound that holds promise for various medical applications.

Latest Patents

Ivan holds a patent for "Compounds with pharmaceutical properties." This patent represents his dedication to advancing medical science and improving healthcare outcomes. He has successfully developed a pharmaceutical compound of a specific formula that showcases his expertise in the field.

Career Highlights

Ivan is currently employed at Lilly, S.A., a leading global pharmaceutical company. His role at Lilly allows him to collaborate with other talented professionals and contribute to groundbreaking research. His career is marked by a commitment to innovation and excellence in pharmaceutical development.

Collaborations

Throughout his career, Ivan has worked alongside esteemed colleagues such as Concepcion Pedregal Tercero and Angel Mazon Ruiz. These collaborations have enriched his research and fostered a dynamic environment for innovation.

Conclusion

Ivan Collado Cano's contributions to the pharmaceutical industry exemplify the impact of dedicated inventors in advancing healthcare. His innovative work continues to inspire future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…